01—Abstract
Summary
Summary of the 8-K filed January 2, 2026. Cited figures are marked; the original filing is the authoritative source.
CoreWeave, Inc. (CRWV) has filed an 8-K detailing an amendment to its DDTL 3.0 Credit Agreement and related Guarantee and Pledge Agreement, originally dated July 28, 2025.
This First Amendment, entered into on December 31, 2025, primarily adjusts financial covenants to better align with anticipated hardware delivery timelines previously discussed by the company. Key modifications include a reduced minimum liquidity requirement for early 2026 and postponed testing dates for significant financial covenants. For investors, the core takeaway is a recalibration of financial flexibility.
The company has secured more accommodating terms regarding liquidity and covenant testing, which is designed to support its growth trajectory amidst potential fluctuations in delivery schedules. The amendment also introduces more lenient equity cure provisions for certain financial covenants, providing a buffer as the company scales its operations. Overall, this filing signals a proactive approach by CoreWeave to manage its financial obligations in line with its operational expansion.
02—Key points
Key Highlights
- Amendment to DDTL 3.0 Credit Agreement and Parent Guarantee and Pledge Agreement executed on December 31, 2025.
- Financial covenants adjusted to align with expected hardware delivery timing.
- Minimum liquidity requirement reduced to $100.0 million for monthly payment dates between March 1, 2026, and May 1, 2026.
- Initial testing date for the debt service coverage ratio covenant postponed to October 31, 2027.
- Initial testing date for the contract realization ratio covenant postponed to February 28, 2026.
- Unlimited equity cures permitted for debt service coverage and contract realization ratio failures until October 28, 2026.
- Post October 28, 2026, up to three consecutive calendar months of equity cures are allowed within any four-month period for these covenants.
03—Questions
Frequently Asked Questions
What is the primary purpose of this amendment?
The primary purpose of the amendment is to adjust the financial covenants within the DDTL 3.0 Credit Agreement to better match CoreWeave's anticipated hardware delivery schedules, as previously discussed on their earnings call. This provides the company with greater financial flexibility.
How does the minimum liquidity requirement change?
The minimum liquidity requirement is temporarily reduced to $100.0 million for monthly payment dates falling between March 1, 2026, and May 1, 2026.
When will CoreWeave begin testing its debt service coverage and contract realization ratio covenants?
The initial testing date for the debt service coverage ratio covenant has been postponed to October 31, 2027. The initial testing date for the contract realization ratio covenant has been postponed to February 28, 2026.
What are the implications of the equity cure provisions?
The amendment significantly enhances equity cure provisions. Unlimited equity cures are allowed for failures related to the debt service coverage ratio and contract realization ratio until October 28, 2026. After this date, up to three consecutive months of equity cures are permitted within any four-month period for these covenants, offering a substantial safety net.
04—Continue